The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly. [electronic resource]
Producer: 20071023Description: 119-23 p. digitalISSN:- 1423-0194
- Acromegaly -- blood
- Adenoma -- blood
- Adult
- Diabetes Mellitus -- drug therapy
- Female
- Growth Hormone-Secreting Pituitary Adenoma -- blood
- Human Growth Hormone -- blood
- Humans
- Hypoglycemic Agents -- administration & dosage
- Insulin-Like Growth Factor I -- metabolism
- Male
- Middle Aged
- PPAR gamma -- agonists
- Prospective Studies
- Rosiglitazone
- Thiazolidinediones -- administration & dosage
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.